Transglutaminase Newsletter September 2010



CHDI Foundation names Zedira as supplier for R&D products in August 2010



Zedira presents preclinical data at Gordon Conference on “Transglutaminases in Human Disease Processes” North  Carolina, USA 18.-23. July 2010



Press release: Zedira takes diagnostics specialist R-Biopharm on board.
Darmstadt – Pfungstadt – Bonn, 18 May 2010




Zedira supports Gordon Conference on "Transglutaminases In Human Disease Processes"



Overview on celiac disease drug development approaches
(published in the German patients magazine "DZG-Aktuell" issue 01/2010, article in German)




Transglutaminase Newsletter March 2010



Zedira presents Open tTGTM at MEDICA in November 2009



Meet Zedira at BIO-Europe in November 2009



Zedira Presents Clinical Candidate for Celiac Disease Therapy
Chicago and Darmstadt, Sep. 23 2009




Zedira co-authors patient information about the implication of transglutaminase in celiac disease
(Article published in "DZG Aktuell" in August 2009; article in German)




Zedira develops drug against Celiac Disease
(Article in Hessen-Biotech NEWS, July 2009; in German)




Transglutaminase Newsletter April 2009



Meet Zedira at 13th International Coeliac Disease Symposium 2009 in April 2009



Meet Zedira at 4th Annual Huntington's Disease Therapeutics Conference in Cannes 2009 in April 2009



Transglutaminase Newsletter February 2009
A complete range of antibodies available from Zedira!




Zedira receives a research grant of 750,000 Euros for the development of novel compounds for thromboprophylaxis in January 2009



Meet Zedira at BIO-Europe in November 2008



Meet Zedira at MEDICA in November 2008



Sanofi-Aventis names Zedira as supplier for R&D products in September 2008



Structure of inhibited tissue transglutaminase published at
XXth International Symposium on Medicinal Chemistry in September 2008




What Links Celiac Disease, Thrombosis, Skin and Hair?
(Article in lab&more September 2008)




Novo Nordisk names Zedira as supplier for R&D products in August 2008



Zedira launches TG6 In Vitro Diagnostic (IVD) in June 2008



Transglutaminase Newsletter April 2008